Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis

被引:3
|
作者
Tsitsou-Kampeli, Afroditi [1 ]
Suzzi, Stefano [1 ,7 ]
Kenigsbuch, Mor [1 ,2 ]
Satomi, Akisawa [1 ,3 ]
Strobelt, Romano [4 ]
Singer, Oded [5 ]
Feldmesser, Ester [5 ]
Purnapatre, Maitreyee
Colaiuta, Sarah Phoebeluc [1 ]
David, Eyal [2 ]
Cahalon, Liora [1 ]
Hahn, Oliver [6 ]
Wyss-Coray, Tony [6 ]
Shaul, Yosef
Amit, Ido
Schwartz, Michal [1 ]
机构
[1] Weizmann Inst Sci, Dept Brain Sci, Rehovot, Israel
[2] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan
[4] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel
[5] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel
[6] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA
[7] Univ Paris Cite, Percept & Act Unit, Inst Pasteur, CNRS UMR3571, F-75015 Paris, France
基金
欧洲研究理事会; 以色列科学基金会;
关键词
NF-KAPPA-B; ALZHEIMERS-DISEASE; CYTOCHROME-P450; 46A1; GENE-EXPRESSION; RECEPTOR LXR; ENZYME; CELLS; MICE; OXYSTEROLS; REVEALS;
D O I
10.1016/j.xcrm.2023.101278
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The choroid plexus (CP) plays a key role in remotely controlling brain function in health, aging, and disease. Here, we report that CP epithelial cells express the brain-specific cholesterol 24-hydroxylase (CYP46A1) and that its levels are decreased under different mouse and human brain conditions, including amyloidosis, ag-ing, and SARS-CoV-2 infection. Using primary mouse CP cell cultures, we demonstrate that the enzymatic product of CYP46A1, 24(S)-hydroxycholesterol, downregulates inflammatory transcriptomic signatures within the CP, found here to be elevated across multiple neurological conditions. In vitro, the pro -inflamma-tory cytokine tumor necrosis factor a (TNF-a) downregulates CYP46A1 expression, while overexpression of CYP46A1 or its pharmacological activation in mouse CP organ cultures increases resilience to TNF-a. In vivo, overexpression of CYP46A1 in the CP in transgenic mice with amyloidosis is associated with better cognitive performance and decreased brain inflammation. Our findings suggest that CYP46A1 expression in the CP im-pacts the role of this niche as a guardian of brain immune homeostasis.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner
    Smiljanic, Kosara
    Lavrnja, Irena
    Djordjevic, Aleksandra Mladenovic
    Ruzdijic, Sabera
    Stojiljkovic, Mirjana
    Pekovic, Sanja
    Kanazir, Selma
    HISTOCHEMISTRY AND CELL BIOLOGY, 2010, 134 (02) : 159 - 169
  • [22] Cholesterol and ocular pathologies: focus on the role of cholesterol-24S-hydroxylase in cholesterol homeostasis
    Fourgeux, Cynthia
    Martine, Lucy
    Gambert-Nicot, Segolene
    Bron, Alain
    Creuzot-Garcher, Catherine
    Bretillon, Lionel
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2015, 22 (02)
  • [23] Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner
    Kosara Smiljanic
    Irena Lavrnja
    Aleksandra Mladenovic Djordjevic
    Sabera Ruzdijic
    Mirjana Stojiljkovic
    Sanja Pekovic
    Selma Kanazir
    Histochemistry and Cell Biology, 2010, 134 : 159 - 169
  • [24] Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
    Toshiya Nishi
    Shinichi Kondo
    Maki Miyamoto
    Sayuri Watanabe
    Shigeo Hasegawa
    Shigeru Kondo
    Jason Yano
    Etsurou Watanabe
    Tsuyoshi Ishi
    Masato Yoshikawa
    Haruhi Kamisaki Ando
    William Farnaby
    Shinji Fujimoto
    Eiji Sunahara
    Momoko Ohori
    Matthew J. During
    Takanobu Kuroita
    Tatsuki Koike
    Scientific Reports, 10
  • [25] Cholesterol 24-hydroxylase and apolipoprotein E gene polymorphisms in Alzheimer's disease in Hungarian population
    Juhász, A
    Rimanóczy, A
    Zana, M
    Bjelik, A
    Kálmán, J
    Gálfi, M
    Janka, Z
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S609 - S609
  • [26] Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
    Nishi, Toshiya
    Kondo, Shinichi
    Miyamoto, Maki
    Watanabe, Sayuri
    Hasegawa, Shigeo
    Kondo, Shigeru
    Yano, Jason
    Watanabe, Etsurou
    Ishi, Tsuyoshi
    Yoshikawa, Masato
    Ando, Haruhi Kamisaki
    Farnaby, William
    Fujimoto, Shinji
    Sunahara, Eiji
    Ohori, Momoko
    During, Matthew J.
    Kuroita, Takanobu
    Koike, Tatsuki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Klotho controls the brain-immune system interface in the choroid plexus
    Zhu, Lei
    Stein, Liana R.
    Kim, Daniel
    Ho, Kaitlyn
    Yu, Gui-Qiu
    Zhan, Lihong
    Larsson, Tobias E.
    Mucke, Lennart
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (48) : E11388 - E11396
  • [28] The immune and metabolic milieu of the choroid plexus as a potential target in brain protection
    Tsitsou-Kampeli, Afroditi
    Suzzi, Stefano
    Schwartz, Michal
    TRENDS IN NEUROSCIENCES, 2024, 47 (08) : 573 - 582
  • [29] AAV gene therapy with cholesterol 24-hydroxylase attenuates Alzheimer phenotype in APP23 mice
    Hudry, Eloise
    Van Dam, Debby
    Kulik, Wim
    De Deyn, Peter Paul
    Stet, Femke
    Ahouansou, Ornella
    Benraiss, Abdellatif
    Delacourte, Andre
    Bougneres, Pierre
    Aubourg, Patrick
    Cartier, Nathalie
    HUMAN GENE THERAPY, 2008, 19 (10) : 1085 - 1086
  • [30] Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy
    Salamone, Alessia
    Terrone, Gaetano
    Di Sapia, Rossella
    Balosso, Silvia
    Ravizza, Teresa
    Beltrame, Luca
    Craparotta, Ilaria
    Mannarino, Laura
    Cominesi, Sara Raimondi
    Rizzi, Massimo
    Pauletti, Alberto
    Marchini, Sergio
    Porcu, Luca
    Zimmer, Till S.
    Aronica, Eleonora
    During, Matthew
    Abrahams, Brett
    Kondo, Shinichi
    Nishi, Toshiya
    Vezzani, Annamaria
    NEUROBIOLOGY OF DISEASE, 2022, 173